Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials*

By Berg Jenny   Fidan Dogan   Lindgren Peter  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2089-2101

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany

By Berger K.   Hessel F.   Kreuzer J.   Smala A.   Diener H.C.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 267-274

Informa Healthcare

Access to resources Recommend Favorite

Modeled cost-effectiveness of the experience corps baltimore based on a pilot randomized trial

By Frick Kevin   Carlson Michelle   Glass Thomas   McGill Sylvia   Rebok George   Simpson Crystal   Fried Linda  

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 81, Iss. 1, 2004-03 ,pp. : 106-117

Springer Publishing Company

Access to resources Recommend Favorite

Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany

By Brüggenjürgen B.   Lindgren P.   Ehlken B.   Rupprecht H.-J.   Willich S.  

The European Journal of Health Economics, Vol. 8, Iss. 1, 2007-03 ,pp. : 51-57

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial

By Majer I. M.   Gelderblom H.   van den Hout W. B.   Gray E.   Verheggen B. G.  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1106-1119

Informa Healthcare

Access to resources Recommend Favorite